Neurology & Neurological Sciences News
Stanford University researchers who study three-dimensional structures of biological molecules, aggressive brain cancers and how to heal diseased hearts are among 33 scientists from 21 institutions announced as new Howard Hughes Medical Institute investigators. The Stanford faculty members are Kristy Red-Horse, associate professor of biology at the School of Humanities and Sciences, Rhiju Das, associate professor of biochemistry, and Michelle Monje, associate professor of neurology.
Kelley M. Skeff GME Professionalism Award
Congratulations, Nick Murray, MD for winning the inaugural Kelley M. Skeff GME Professionalism Award! This award, named in honor of Dr. Kelley Skeff (prior Stanford internal medicine residency program director and internationally known leader in education), recognizes high levels of excellence and compassion in professional behavior through collaborative work with colleagues, faculty and staff from across the institution. Congrats, Dr. Murray!
Oscar Salvatierra Award
Congratulations to Jeffrey Dunn, MD, inaugural award winner of the Oscar Salvatierra Award for Exceptional Service to Stanford medical students and the Stanford University School of Medicine. Dr. Dunn built the Neurology clerkship into a model of national excellence and the highest rated clerkship in the SOM for more than a decade, inspiring more than a thousand medical students during his tenure.
Congratulations to Reena Thomas, MD, PhD for receiving the Stanford Award for Excellence in Promotion of Diversity and Societal Citizenship. This award was established to recognize individuals that have made significant contributions to the promotion of the principles of diversity and societal citizenship at the Stanford School of Medicine.
Stanford neuro-oncologist Michelle Monje teamed up with Craig Thomas at the National Center for Advancing Translational Sciences and Kathy Warren from NCI (now at DFCI) to perform high-throughput drug screening of patient-derived cultures of diffuse intrinsic pontine glioma, the leading cause of brain tumor-related death in children. The study, led by MD PhD student and future neurologist Grant L. Lin, uncovered a promising two-drug combination that shows benefit in preclinical studies and will advance to clinical trial soon. The mechanism of drug-drug synergy was determined to be metabolic collapse, highlighting a key avenue for future strategies in this lethal childhood brain cancer. Stanford neurologist Kati Andreasson’s lab contributed importantly to the metabolic mechanistic studies. Full Story